Re: Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
Evan
E
Cameron
D006801:Humans; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D012597:Sclerosing Solutions / Q000008:administration & dosage*; D015911:Sclerotherapy; D014648:Varicose Veins / Q000628:therapy*
D012597:Sclerosing Solutions; D011092:Polyethylene Glycols